Skip to content

Laurus Labs: Anti-retroviral business disappoints but synthesis-led growth intact

Capex execution will be key to the company’s growth prospects; diversification initiatives should be supportive

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish